Yeast Model Connects Alzheimer's Disease Risk and Amyloid Beta Toxicity, Whitehead Institute Study

Published: Oct 31, 2011

In a development that sheds new light on the pathology of Alzheimer's disease (AD), a team of Whitehead Institute scientists has identified connections between genetic risk factors for the disease and the effects of a peptide toxic to nerve cells in the brains of AD patients.

Back to news